Genomics of acute myeloid leukemia: The next generation

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Acute myeloid leukemia (AML) is, as other types of cancer, a genetic disorder of somatic cells. The detection of somatic molecular abnormalities that may cause and maintain AML is crucial for patient stratification. The development of mutation-specific therapeutic interventions will hopefully increase cure rates and improve patients' quality of life. This review illustrates how next generation sequencing technologies are changing the study of cancer genomics of adult AML patients.

Original languageEnglish
Article numberArticle 40
JournalFrontiers in Oncology
Volume2 MAY
DOIs
Publication statusPublished - 2012

Fingerprint

Genomics
Acute Myeloid Leukemia
Inborn Genetic Diseases
Neoplasms
Quality of Life
Technology
Mutation
Therapeutics

Keywords

  • Acute myeloid leukemia
  • Next generation sequencing
  • Recurrent mutations
  • Somatic mutations

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Genomics of acute myeloid leukemia : The next generation. / Riva, Laura; Luzi, Lucilla; Pelicci, Pier Giuseppe.

In: Frontiers in Oncology, Vol. 2 MAY, Article 40, 2012.

Research output: Contribution to journalArticle

@article{a85d5d1cd1314abd9dd926cea0d22cc9,
title = "Genomics of acute myeloid leukemia: The next generation",
abstract = "Acute myeloid leukemia (AML) is, as other types of cancer, a genetic disorder of somatic cells. The detection of somatic molecular abnormalities that may cause and maintain AML is crucial for patient stratification. The development of mutation-specific therapeutic interventions will hopefully increase cure rates and improve patients' quality of life. This review illustrates how next generation sequencing technologies are changing the study of cancer genomics of adult AML patients.",
keywords = "Acute myeloid leukemia, Next generation sequencing, Recurrent mutations, Somatic mutations",
author = "Laura Riva and Lucilla Luzi and Pelicci, {Pier Giuseppe}",
year = "2012",
doi = "10.3389/fonc.2012.00040",
language = "English",
volume = "2 MAY",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - Genomics of acute myeloid leukemia

T2 - The next generation

AU - Riva, Laura

AU - Luzi, Lucilla

AU - Pelicci, Pier Giuseppe

PY - 2012

Y1 - 2012

N2 - Acute myeloid leukemia (AML) is, as other types of cancer, a genetic disorder of somatic cells. The detection of somatic molecular abnormalities that may cause and maintain AML is crucial for patient stratification. The development of mutation-specific therapeutic interventions will hopefully increase cure rates and improve patients' quality of life. This review illustrates how next generation sequencing technologies are changing the study of cancer genomics of adult AML patients.

AB - Acute myeloid leukemia (AML) is, as other types of cancer, a genetic disorder of somatic cells. The detection of somatic molecular abnormalities that may cause and maintain AML is crucial for patient stratification. The development of mutation-specific therapeutic interventions will hopefully increase cure rates and improve patients' quality of life. This review illustrates how next generation sequencing technologies are changing the study of cancer genomics of adult AML patients.

KW - Acute myeloid leukemia

KW - Next generation sequencing

KW - Recurrent mutations

KW - Somatic mutations

UR - http://www.scopus.com/inward/record.url?scp=84876985939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876985939&partnerID=8YFLogxK

U2 - 10.3389/fonc.2012.00040

DO - 10.3389/fonc.2012.00040

M3 - Article

AN - SCOPUS:84876985939

VL - 2 MAY

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

M1 - Article 40

ER -